Livia Lamartina

Université Paris-Saclay — France

Medicine · Health Sciences

35h-index5.5kcitations229works2.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Thyroid Cancer Diagnosis and Treatment(173), Thyroid and Parathyroid Surgery(45), Radiation Dose and Imaging(28), Medical Imaging Techniques and Applications(26), Cancer, Hypoxia, and Metabolism(25)

Publications228 total

Cancers de la thyroïde, nouvelles perspectives et prise en charge
EMC - Endocrinologie - Nutrition·2025
Poorly differentiated grade 3 gastroenteropancreatic neuroendocrine carcinomas: diagnosis, workup and management
Hépato-Gastro & Oncologie Digestive·2025
Supplementary Figure S2 from A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and <sup>131</sup>I in Metastatic Radioactive Iodine Refractory <i>BRAF</i> p.V600E-Mutated Differentiated Thyroid Cancer
2025Open Access
Supplementary Figure S1 from A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and <sup>131</sup>I in Metastatic Radioactive Iodine Refractory <i>BRAF</i> p.V600E-Mutated Differentiated Thyroid Cancer
2025Open Access
Supplementary Table S5 from A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and <sup>131</sup>I in Metastatic Radioactive Iodine Refractory <i>BRAF</i> p.V600E-Mutated Differentiated Thyroid Cancer
2025Open Access
Supplementary Table S1 from A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and <sup>131</sup>I in Metastatic Radioactive Iodine Refractory <i>BRAF</i> p.V600E-Mutated Differentiated Thyroid Cancer
2025Open Access
Supplementary Table S7 from A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and <sup>131</sup>I in Metastatic Radioactive Iodine Refractory <i>BRAF</i> p.V600E-Mutated Differentiated Thyroid Cancer
2025Open Access
Supplementary Table S3 from A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and <sup>131</sup>I in Metastatic Radioactive Iodine Refractory <i>BRAF</i> p.V600E-Mutated Differentiated Thyroid Cancer
2025Open Access
Supplementary Figure S3 from A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and <sup>131</sup>I in Metastatic Radioactive Iodine Refractory <i>BRAF</i> p.V600E-Mutated Differentiated Thyroid Cancer
2025Open Access
Supplementary Table S2 from A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and <sup>131</sup>I in Metastatic Radioactive Iodine Refractory <i>BRAF</i> p.V600E-Mutated Differentiated Thyroid Cancer
2025Open Access
Supplementary Table S4 from A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and <sup>131</sup>I in Metastatic Radioactive Iodine Refractory <i>BRAF</i> p.V600E-Mutated Differentiated Thyroid Cancer
2025Open Access
Supplementary Table S6 from A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and <sup>131</sup>I in Metastatic Radioactive Iodine Refractory <i>BRAF</i> p.V600E-Mutated Differentiated Thyroid Cancer
2025Open Access
Validation of the International Medullary Thyroid Carcinoma Grading System in Patients with Distant Metastases
Thyroid·2025Open Access
Case Report: Locally invasive thyroid metastases from renal cell carcinoma: surgery after neoadjuvant therapy
Frontiers in Oncology·2025Open Access
ENDOCAN-TUTHYREF guidelines. Locoregional therapies for locally advanced and/or metastatic thyroid cancer
Annales d Endocrinologie·2025· 2 cited
ENDOCAN TUTHYREF network consensus recommendations: Anaplastic thyroid cancer
Annales d Endocrinologie·2025· 2 citedOpen Access
Paediatric thyroid cancer management in france: a TUTHYREF network
Endocrine Abstracts·2025
ENDOCAN TUTHYREF network consensus recommendations: Refractory follicular-derived thyroid cancer
Annales d Endocrinologie·2025· 2 cited
Dosimetry in Advanced Thyroid Cancer
Endocrinology and Metabolism Clinics of North America·2025
ENDOCAN TUTHYREF network consensus recommendations for refractory thyroid cancer management
Annales d Endocrinologie·2025· 1 cited
page 1 of 12Next →

Frequent Co-authors

Cosimo Durante(28), Sébastiano Filetti(23), Giorgio Grani(21), Sophie Leboulleux(14), Luciano Giacomelli(13), Éric Baudin(13), Julien Hadoux(12), Abir Al Ghuzlan(11), Martin Schlumberger(11), Marco Biffoni(9), Domenico Meringolo(8), Marianna Maranghi(8), Dana M. Hartl(8), Massimo Torlontano(7), Rosa Falcone(7), Valeria Ramundo(7), Christine Do Cao(7), Teresa Montesano(7), Rocco Bruno(6), Dario Tumino(6)